Pedro Luiz Serrano Uson Junior

Precision Medicine Targeting FGFR2 Genomic Alterations in Advanced Cholangiocarcinoma: Current State and Future Perspectives

R. Pestana, G. Botrus, Miguel Zugman, 2022, Frontiers in Oncology.

Precision approaches for cholangiocarcinoma: progress in clinical trials and beyond

M. Borad, Pedro Luiz Serrano Uson Junior, P. U. Uson Junior, 2021, Expert opinion on investigational drugs.

FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations

James M. Bogenberger, G. Gores, A. Mansfield, 2021, Digestive Diseases and Sciences.

Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy

G. Gores, A. Mansfield, M. Barrett, 2021, medRxiv.

Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR)

D. V. Von Hoff, Haiyong Han, G. Botrus, 2022, International journal of molecular sciences.

Novel precision therapies for cholangiocarcinoma: an overview of clinical trials

M. Borad, H. Babiker, Pedro Luiz Serrano Uson Junior, 2023, Expert opinion on investigational drugs.

Characterization of Morreton Virus (MORV) as a Novel Oncolytic Virotherapy Platform for Liver Cancers

James M. Bogenberger, M. Barrett, R. Vile, 2022, bioRxiv.

Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation

M. Borad, B. Aqel, A. Moss, 2022, Cancers.